Carrie A. Roll: Lawyer with Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Carrie A. Roll


Peer Rating

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials

Practice Areas

  • Mergers
  • Acquisitions & Other Transactions
  • Fraud & Abuse
  • Compliance & Regulatory Counseling
  • Accreditation
  • Licensing & Certification
  • Health Law
  • Health Care
Contact InfoTelephone: 202.434.7350
Fax: 202-434-7400
Internet: Each Attorney's Internet Address takes the following form: first initial, last name (e.g.,
University Colorado State University, B.S., 1998
Law SchoolUniversity of Maryland, J.D., 2008
Admitted2008, Maryland; District of Columbia

Carrie's practice involves a variety of transactional, regulatory, and fraud and abuse matters.

Carrie's transactional experience focuses on advising health care clients on joint ventures, mergers and acquisitions, service agreements, and corporate stock and asset acquisitions. She has served as corporate and regulatory counsel to pharmacy benefit managers, retail pharmacies, and health care providers in acquisitions, which included due diligence, licensing, change of ownership, and contracting. Carrie has also assisted in the preparation and negotiation of pharmacy benefit manager agreements, pharmacy network agreements, pharmaceutical distribution agreements, and rebate agreements.

She also advises health care clients on a variety of regulatory issues, such as federal and state anti-kickback and self-referral laws, and state regulatory issues, including corporate practice of medicine and fee-splitting prohibitions, telemedicine and online prescribing requirements, certificate of need applications, and laboratory billing restrictions.

Carrie provides compliance advice to clients in structuring proposed transactions and business arrangements to comply with the anti-kickback statute and the Stark fraud and abuse laws as well as other applicable state and federal regulatory requirements. Carrie has counseled a wide range of health care providers, including pharmacies, renal dialysis providers, pharmacy benefit managers, physicians and physician groups, mental health providers, health care clinics, laboratories, hospital systems, practice management companies, and life sciences companies.

Before attending law school, Carrie worked as a microbiologist at the National Institutes of Health.


• Co-author, OIG Special Advisory Bulletin Provides Guidance on Application of Federal Anti-Kickback Statute to Pharmaceutical Manufacturer Copayment Coupons, BNA's Health Care Fraud Report ( 10.15.2014 )
• Co-author, Proposed Rule Issued by OIG Realigns Its Enforcement Views with Health Care Reform Goals, Health Care Alert ( 10.09.2014 )
• Co-author, The Medical Home - A New Foundation for Health Care, Health Care Reform Advisory ( 01.04.2010 )
• The Human Papillomavirus Vaccine: Should It Be Mandatory or Voluntary?, Journal of Health Care Law & Policy ( 2007 )


Documents by this lawyer on

Subscribe to this feed

HHS Announces $840 Million Initiative to Improve Patient Care and Lower Healthcare Costs
Carrie A. Roll,Andrew J. Shin, November 5, 2014
Last week, the Department Health and Human Services (HHS) announced that it will invest $840 million over the next four years to support 150,000 clinicians through a combination of incentives, tools, and information to encourage clinicians and other health care providers “to move from...

Proposed Rule Issued by OIG Realigns Its Enforcement Views with Health Care Reform Goals
Theresa C. Carnegie,Thomas S. Crane,Carrie A. Roll,Stephanie D. Willis, October 15, 2014
Fridays never seem to be slow in the health care regulatory world. On Friday, October 3rd, the HHS Office of the Inspector General (OIG) issued a highly anticipated proposed rule (the Proposed Rule) that provides amendments to the Anti-Kickback Statute’s regulatory safe harbors (AKS Safe...

OIG Approves Manufacturer’s Direct-to-Patient Discount Sales Program
Theresa C. Carnegie,Carrie A. Roll, August 22, 2014
The Office of Inspector General (“OIG”) recently posted an Advisory Opinion approving a pharmaceutical manufacturer’s direct-to-patient product sales program. While this Advisory Opinion cannot be relied upon by anyone other than the requestor, it potentially opens the door for...

Profile Visibility
#3,579 in weekly profile views out of 56,331 lawyers in Washington, District of Columbia
#114,561 in weekly profile views out of 1,648,112 total lawyers Overall

Office Information

Carrie A. Roll

701 Pennsylvania Avenue, N.W.
WashingtonDC 20004-2608


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now